Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.54 | 16.75 |
| PEG Ratio (TTM) | 0.04 | 1.43 |
| P/S Ratio (TTM) | 0.43 | 1.53 |
| P/B Ratio (TTM) | 0.68 | 2.95 |
| P/FCF Ratio (TTM) | 1.99 | 7.12 |
| Price to 5YR AVG Earnings Ratio | -76.75 | 18.63 |
| Price to 5YR AVG FCF Ratio | 9.68 | 11.67 |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.17% | 4.17% |
| ROE (TTM) | 5.17% | 16.35% |
| Net Profit Margin (TTM) | 3.17% | 9.68% |
| ROIC 5YR AVG | 18.22% | 8.16% |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 42.60% | -245.91% | -223.14% |
| Revenue | 3.05% | 0.33% | 0.93% |
| Net Income | 41.81% | -245.13% | -222.87% |
| Cash Flow | 71.30% | -32.82% | 2,725.05% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.53 | 1.28 |
| Quick Ratio (TTM) | 0.97 | 3.38 |
| D/E Ratio (TTM) | 0.16 | 0.31 |
| Interest Coverage (TTM) | 55.08 | 18.02 |
| Piotroski F-Score | 3 | 7 |
| Altman Z-Score | 0.50 | 1.83 |
| LTL to 5YR AVG FCF | 0.97 | 1.41 |
| Shares Outstanding Growth 5YR AVG | 0.12% | -1.61% |